Code | 3040E | ||||||||||
MA number | 18/0037/23-S | ||||||||||
Product Form: | tbl flm 196x50 mg/850 mg (blis.OPA/Al/PVC/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | TAD Pharma GmbH, Germany | ||||||||||
Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 17.02.2023 |
Validity: | 17.02.2028 |
PIL: | PIL_Asigefort filmom obalené tablety_03.2024.pdf |
SPC: | SPC_Asigefort filmom obalené tablety_03.2024.pdf |
Safety feature | Yes |
Data update: | 17.02.2023 |